Tag Archives: BCMA

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients

March 5, 2017

0 Comments

Michael Ghermezi, Mingjie Li, Suzie Vardanyan, Nika Manik Harutyunyan, Jillian Gottlieb, Ariana Berenson, Tanya M. Spektor, Claudia Andreu-Vieyra, Sophia Petraki, Eric Sanchez, Kyle Udd, Cathy S. Wang, Regina A. Swift, Haiming Chen, James R Berenson Haematologica December 2016 : haematol.2016.150896; doi:10.3324/haematol.2016.150896 Abstract B-cell maturation antigen is expressed on plasma cells. In this study, we have […]

Continue reading...

Several MAJOR new items have emerged from recent research efforts at IMBCR

February 4, 2014

0 Comments

First, we have uncovered a new serum marker for multiple myeloma which is a protein called B-cell maturation antigen or BCMA for short.  This protein is shed off the myeloma cells into the blood.  We have shown that the levels of BCMA predict outcomes for myeloma patients.  Lower levels are associated with better survival.  In […]

Continue reading...

Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival

September 18, 2012

Comments Off on Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival

Br J Haematol. 2012 Sep;158(6):727-38. doi: 10.1111/j.1365-2141.2012.09241.x. Epub 2012 Jul 18. Sanchez E, Li M, Kitto A, Li J, Wang CS, Kirk DT, Yellin O, Nichols CM, Dreyer MP, Ahles CP, Robinson A, Madden E, Waterman GN, Swift RA, Bonavida B, Boccia R, Vescio RA, Crowley J, Chen H, Berenson JR. Abstract Although TNFRSF17 (also […]

Continue reading...